Nanoscope Therapeutics

Nanoscope Therapeutics is pushing forward gene therapy using photosensitive compounds and light-assisted gene transfer to restore vision to the millions of visually impaired people affected by retinal degenerative disease, for which there is currently no remedy. We employ natural light-sensitive substances to re-sensitize the retina to low light levels. Our light-aided gene therapy is precisely targeted at geographical atrophies without disrupting the functional retina network. Our team has extensive expertise in the development of ophthalmic products and the clinical application of groundbreaking research.